References
- Lazahortes G, Campan L. Brain edema: symptomatology, clinical forms, diagnosis and treatment. In: Vinken PJBruyn GW eds. Handbook of Clinical Neurology Amsterdam: North Holland Publishing Company. 1974; 16, Chapter 6.
- Frank M, Nahata MC, Hilty MD. Glycerol: a review of its pharmacology, pharmacokinetics, adverse reactions, and clinical use. Pharmacotherapy 1981; 1:147–160.
- Righetti E, Celani MG, Cantisani T, Sterzi R, Boysen G, Ricci S. Glycerol for acute stroke: a Cochrane systematic review. J Neurol 2002; 294:445–451.
- Neuhauser H. Epidemiology of vertigo. Curr Opin Neurol 2007; 20(1):40–46.
- Klockhoff I, Lindblom U. Endolymphatic hydrops revealed by glycerol test. Acta Otolaryngol 1966; 61:459–462.
- Morgenstern C. Der Klockhoff-Test beim M Ménière. HNO 1993; 41(A):20.
- Naftalin L, Mallett KJH. How Does the Klohoff-Lindblom test work?. Lancet 1978; 2:103–104.
- Arnold W. Zur Pathophysiologie und Klinik des Morbus Meniere. Laryngol Rhinol Otol 1981; 60:601–608.
- Thomsen J, Vesterhauge S. A critical evaluation of the glycerol test in Ménière's disease. J Otolaryngol 1979; 8:145–150.
- Bartsch W, Sponer G, Dietmann K, Fuchs G. Acute toxicity of various solvents in the mouse and rat. LD50 of ethanol, diethylacetamide, dimethylformamide, dimethylsulfoxide, glycerine, N-methylpyrrolidone, polyethylene glycol 400, 1,2-propanediol and Tween 20. Arzneimittel forschung 1976; 26(8):1581–1583.
- Padoan S. Oral versus i.v. administration of the glycerol test: side-effects and usefulness. Acta Otolaryngol 2003; 123:482–487.
- GESTIS-database on hazardous substances. 2007.
- Sroka K. Vergiftung durch glyzerin. Münchner Medizinische Wochenschrift 1952; 28:1418.
- Martindale W. The Extra Pharmacopoeia. 29th. London:The Pharmaceutical Press; 1989.
- Sommer S, Nau R, Wieland E, Prange HW. Pharmacokinetics of glycerol administered orally in healthy volunteers. Arzneimittelforschung – Drug Res 1993; 43:744–747.
- Tourtellotte W, Reinglass JM, Newkirk TA. Cerebral dehydratation action of glycerol. Clin Pharmacol Ther 1972; 13:159–171.
- Schwarz K, Bottermann P, Claussen G, Kopetz K, Eymer KP. Untersuchungen über die Resorption und die biologische Halbwertszeit von Glycerin beim Menschen. Klin Wochenschr 1952; 40:1183–1187.
- Lin E. Glycerol utilization and its regulation in mammals. Annu Rev Biochem 1977; 46:765–795.
- Olbermann M, Grünert A, Bässler KH. Biokinetische Charakterisierung der Glycerinverwertung beim Menschen. Infusionstherapie 1977; 4:68–70.
- Bingel U, Andresen H, Liepert J. Acute encephalopathy due to glycerol over-consumption. J Neurol 2006; 253:125–126.
- Klotzsch S, McNamara JR. Triglyceride measurements: a review of methods and interferences. Clin Chem 1990; 36:1605–1613.
- Robergs R, Griffin SE. Glycerol – biochemistry, pharmacokinetics and clinical and practical application. Sports Med 1998; 26:154–167.
- Thomas L. Labor und Diagnose. In: . 4th ed. Marburg, Germany:Med.Verl. Ges; 1992..
- Nauck M, Winkler Siekmeier R, Marangos N, Richter B, März W, Wieland H. Pseudo-pseudohypertriglyceridemia: a case of increased free glycerol without evidence for glycerol kinase deficiency. Clin Chem 1995; 41:619–620.
- Rapoport S, Hori M, Klatzo I. Reversible osmotic opening of the blood-brain barrier. Science 1971; 173:1026–1028.
- Wang J, Chen JL. Glycerol dehydrates oedematous as well as normal brain in dogs. Clin Exp. Pharmacol Physiol 1994; 21:263–270.
- Nau R, Prins FJ, Kolenda H, Prange HW. Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol. Eur. J Clin Pharmacol 1992; 42: 181–185.
- McCurdy D, Schneider B, Scheie HG. Oral glycerol: the mechanism of intraocular hypotension. Am J Opthalmol 1966; 61: 1244–1249.
- Pitlick WH, Pirikitakuhlr P, Painter M, Wessel H. Effects of glycerol and hyperosmolality on intracranial pressure. Clin Pharmacol Ther 1982; 31(4):466–471.